TPW
TMO icon

Transatlantique Private Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Transatlantique Private Wealth’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.96M Buy
5,107
+33
+0.7% +$18.7K 0.93% 24
2025
Q3 		$2.46M Sell
5,074
-238
-4% -$111K 0.81% 30
2025
Q2 		$2.15M Buy
5,312
+94
+2% +$39.3K 0.79% 30
2025
Q1 		$2.6M Buy
5,218
+322
+7% +$174K 1.04% 24
2024
Q4 		$2.55M Sell
4,896
-416
-8% -$229K 0.97% 25
2024
Q3 		$3.29M Sell
5,312
-422
-7% -$250K 1.26% 15
2024
Q2 		$3.15M Buy
5,734
+24
+0.4% +$13.7K 1.29% 16
2024
Q1 		$3.3M Buy
5,710
+313
+6% +$176K 1.44% 8
2023
Q4 		$2.85M Sell
5,397
-441
-8% -$213K 1.33% 9
2023
Q3 		$2.94M Sell
5,838
-44
-0.7% -$23.4K 1.58% 7
2023
Q2 		$3.07M Buy
5,882
+13
+0.2% +$7.01K 1.6% 7
2023
Q1 		$3.36M Buy
5,869
+152
+3% +$85.7K 1.86% 4
2022
Q4 		$3.14M Buy
5,717
+516
+10% +$273K 1.88% 5
2022
Q3 		$2.64M Buy
5,201
+453
+10% +$254K 1.76% 6
2022
Q2 		$2.58M Buy
+4,748
New +$2.61M 1.8% 4

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Transatlantique Private Wealth's TMO Position: Q4 2025 in Review

Transatlantique Private Wealth increased its Thermo Fisher Scientific (TMO) stake by 0.65% in Q4 2025, buying an estimated $18.7K and bringing the position to 5,107 shares worth $2.96M. The position accounts for 0.93% of the portfolio, ranked #24.

Transatlantique Private Wealth first reported a position in TMO in Q2 2022 and has held it in 15 quarters since. The position peaked at $3.36M in Q1 2023. 2,700 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Transatlantique Private Wealth held 5,107 shares of Thermo Fisher Scientific worth $2.96M as of Q4 2025.
  • Transatlantique Private Wealth bought 33 Thermo Fisher Scientific shares in Q4 2025, an estimated $18.7K.
  • Thermo Fisher Scientific made up 0.93% of Transatlantique Private Wealth's portfolio in Q4 2025, its #24 holding.
  • Transatlantique Private Wealth first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 15 quarters since.
  • Transatlantique Private Wealth's Thermo Fisher Scientific position peaked at $3.36M in Q1 2023.
  • 2,700 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.